Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00003178
Other study ID # 9720
Secondary ID COG-P9720POG-972
Status Completed
Phase Phase 2
First received June 2, 2000
Last updated July 24, 2014
Start date March 1998
Est. completion date March 2007

Study information

Verified date July 2014
Source Children's Oncology Group
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.

PURPOSE: Phase II trial to study the effectiveness of idarubicin and cladribine in treating children who have recurrent acute myeloid leukemia.


Description:

OBJECTIVES:

- Determine the complete response rate in children with primary refractory or recurrent acute myeloid leukemia (AML) or secondary AML treated with idarubicin and cladribine. (Refractory AML stratum closed as of 4/3/01) (Secondary AML stratum closed as of 04/02/02)

- Compare the remission reinduction rates in children who relapse at 1 year or earlier vs more than 1 year from time of initial remission.

- Determine the toxic effects of this regimen in this patient population.

OUTLINE: Patients are stratified according to disease characteristics (primary or secondary acute myeloid leukemia (AML) with first untreated relapse vs primary refractory AML). (Refractory AML stratum closed as of 4/3/01) (Secondary AML stratum closed as of 04/02/02)

Patients receive idarubicin IV over 15 minutes on days 1-3, cladribine IV over 2 hours on days 1-5, and filgrastim (G-CSF) subcutaneously beginning on day 6 and continuing until blood counts have recovered for 2 days. Treatment repeats every 3 weeks for up to 2 courses in the absence of disease progression or unacceptable toxicity. Patients who achieve complete response after completion of course 1 may proceed to other chemotherapy or bone marrow transplantation at the discretion of the protocol investigator. Patients with extramedullary disease may receive intrathecal chemotherapy or radiotherapy to symptomatic sites.

Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually thereafter.

PROJECTED ACCRUAL: A total of 51-102 patients will be accrued for this study within 3 years.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date March 2007
Est. primary completion date December 2004
Accepts healthy volunteers No
Gender Both
Age group N/A to 21 Years
Eligibility DISEASE CHARACTERISTICS:

- One of the following diagnoses:

- Acute myeloid leukemia (AML) (FAB M0-M7)

- Secondary AML in first relapse (Secondary AML stratum closed as of 04/02/02)

- AML in primary induction failure (Refractory AML stratum closed as of 04/03/01)

- Myelodysplastic syndromes (MDS) (not related to Down syndrome) (MDS stratum closed as of 04/03/01)

- Extramedullary disease allowed

- Relapse more than 6 months after allogeneic or autologous bone marrow transplantation allowed

PATIENT CHARACTERISTICS:

Age:

- Under 21 at diagnosis

Performance status:

- Karnofsky 50-100% (over 10 years)

- Lansky 50-100% (10 years and under)

Life expectancy:

- Not specified

Hematopoietic:

- Not specified

Hepatic:

- Bilirubin less than 1.5 mg/dL

- ALT less than 3 times normal

Renal:

- Creatinine less than 2 times normal

Cardiovascular:

- Shortening fraction greater than 29%

- Ejection fraction greater than 55% with normal wall motion

Other:

- No uncontrolled infection

- Not pregnant or nursing

PRIOR CONCURRENT THERAPY:

Biologic therapy:

- See Disease Characteristics

Chemotherapy:

- At least 12 weeks since prior idarubicin and recovered

- At least 2 weeks since other prior chemotherapy and recovered

Endocrine therapy:

- Not specified

Radiotherapy:

- Not specified

Surgery:

- Not specified

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
filgrastim

Drug:
cladribine

idarubicin


Locations

Country Name City State
Australia Royal Children's Hospital Brisbane Queensland
Australia Women's and Children's Hospital North Adelaide South Australia
Australia Royal Children's Hospital Parkville Victoria
Australia Princess Margaret Hospital for Children Perth Western Australia
Australia Sydney Children's Hospital Randwick New South Wales
Australia Children's Hospital at Westmead Westmead New South Wales
Canada Alberta Children's Hospital Calgary Alberta
Canada Cross Cancer Institute Edmonton Alberta
Canada IWK Health Centre Halifax Nova Scotia
Canada Children's Hospital Hamilton Ontario
Canada Children's Hospital of Western Ontario London Ontario
Canada Hopital Sainte Justine Montreal Quebec
Canada McGill University Health Center - Montreal Children's Hospital Montreal Quebec
Canada Children's Hospital of Eastern Ontario Ottawa Ontario
Canada Allan Blair Cancer Centre Regina Saskatchewan
Canada Centre Hospitalier de L'Universite Laval Sainte Foy Quebec
Canada Laval University Medical Center Sainte-Foy Quebec
Canada Saskatoon Cancer Centre Saskatoon Saskatchewan
Canada Janeway Children's Health and Rehabilitation Centre St. John's Newfoundland and Labrador
Canada Hospital for Sick Children Toronto Ontario
Canada British Columbia Children's Hospital Vancouver British Columbia
Canada CancerCare Manitoba Winnipeg Manitoba
Netherlands Academisch Ziekenhuis Groningen Groningen
New Zealand Starship Children's Hospital Auckland
Puerto Rico University of Puerto Rico School of Medicine Medical Sciences Campus San Juan
Puerto Rico San Jorge Childrens Hospital Santurce
Switzerland Swiss Pediatric Oncology Group Bern Bern
Switzerland Swiss Pediatric Oncology Group Geneva Geneva
Switzerland Swiss Pediatric Oncology Group Lausanne Lausanne
United States Children's Hospital Medical Center of Akron Akron Ohio
United States Cancer Center of Albany Medical Center Albany New York
United States University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico
United States Texas Tech University Health Sciences Center School of Medicine Amarillo Texas
United States Mott Children's Hospital Ann Arbor Michigan
United States Mission Saint Joseph's Health System Asheville North Carolina
United States Children's Healthcare of Atlanta - Scottish Rite Atlanta Georgia
United States Emory University Hospital - Atlanta Atlanta Georgia
United States Medical College of Georgia Comprehensive Cancer Center Augusta Georgia
United States Children's Hospital of Austin Austin Texas
United States Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland
United States Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland
United States Sinai Hospital of Baltimore Baltimore Maryland
United States Eastern Maine Medical Center Bangor Maine
United States University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama
United States Mountain States Tumor Institute Boise Idaho
United States Dana-Farber Cancer Institute Boston Massachusetts
United States Floating Hospital for Children Boston Massachusetts
United States Albert Einstein Clinical Cancer Center Bronx New York
United States Brookdale University Hospital and Medical Center Brooklyn New York
United States Brooklyn Hospital Center Brooklyn New York
United States Maimonides Medical Center Brooklyn New York
United States State University of New York Health Science Center at Brooklyn College of Medicine Brooklyn New York
United States Roswell Park Cancer Institute Buffalo New York
United States Vermont Cancer Center Burlington Vermont
United States Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina
United States Medical University of South Carolina Charleston South Carolina
United States West Virginia University - Charleston Charleston West Virginia
United States Carolinas Medical Center Charlotte North Carolina
United States Presbyterian Healthcare Charlotte North Carolina
United States Cancer Center at the University of Virginia Charlottesville Virginia
United States Children's Memorial Hospital - Chicago Chicago Illinois
United States Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois
United States University of Chicago Cancer Research Center Chicago Illinois
United States University of Illinois at Chicago Chicago Illinois
United States Children's Hospital Medical Center - Cincinnati Cincinnati Ohio
United States Cleveland Clinic Taussig Cancer Center Cleveland Ohio
United States Ireland Cancer Center Cleveland Ohio
United States Palmetto Health South Carolina Cancer Center Columbia South Carolina
United States Children's Hospital of Columbus Columbus Ohio
United States Medical City Dallas Hospital Dallas Texas
United States Simmons Cancer Center - Dallas Dallas Texas
United States Geisinger Medical Center Danville Pennsylvania
United States Children's Medical Center - Dayton Dayton Ohio
United States Childhood Hematology/Oncology Associates Denver Colorado
United States Children's Hospital of Denver Denver Colorado
United States Presbyterian-St Luke's Medical Center Denver Colorado
United States John Stoddard Cancer Center Des Moines Iowa
United States Raymond Blank Memorial Hospital for Children Des Moines Iowa
United States Children's Hospital of Michigan Detroit Michigan
United States Henry Ford Hospital Detroit Michigan
United States St. John Hospital and Medical Center Detroit Michigan
United States Southern California Permanente Medical Group Downey California
United States City of Hope Comprehensive Cancer Center Duarte California
United States St. Mary's/Duluth Clinic Cancer Center Duluth Minnesota
United States Duke Comprehensive Cancer Center Durham North Carolina
United States Michigan State University East Lansing Michigan
United States Inova Fairfax Hospital Falls Church Virginia
United States Dakota Cancer Institute Fargo North Dakota
United States University of Connecticut Health Center Farmington Connecticut
United States Hurley Medical Center Flint Michigan
United States Broward General Medical Center Fort Lauderdale Florida
United States Children's Hospital of Southwest Florida Fort Myers Florida
United States Cook Children's Medical Center - Fort Worth Fort Worth Texas
United States Shands Hospital and Clinics, University of Florida Gainesville Florida
United States University of Texas Medical Branch Galveston Texas
United States Spectrum Health and DeVos Children's Hospital Grand Rapids Michigan
United States Bellin Memorial Hospital Green Bay Wisconsin
United States CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay Wisconsin
United States St. Vincent Hospital Green Bay Wisconsin
United States Children's Hospital of Greenville Hospital System Greenville South Carolina
United States East Carolina University School of Medicine Greenville North Carolina
United States Hackensack University Medical Center Hackensack New Jersey
United States Milton S. Hershey Medical Center Hershey Pennsylvania
United States Joe DiMaggio Children's Hospital at Memorial Hollywood Florida
United States Cancer Research Center of Hawaii Honolulu Hawaii
United States MBCCOP - Hawaii Honolulu Hawaii
United States Tripler Army Medical Center Honolulu Hawaii
United States Baylor College of Medicine Houston Texas
United States University of Texas - MD Anderson Cancer Center Houston Texas
United States Cabell-Huntington Hospital, Inc Huntington West Virginia
United States Indiana University Cancer Center Indianapolis Indiana
United States St. Vincent Hospital and Health Care Center Indianapolis Indiana
United States Holden Comprehensive Cancer Center Iowa City Iowa
United States University of Mississippi Medical Center Jackson Mississippi
United States Nemours Children's Clinic Jacksonville Florida
United States East Tennessee State University Cancer Center at JCMC Johnson City Tennessee
United States Bronson Methodist Hospital Kalamazoo Michigan
United States Children's Mercy Hospital Kansas City Missouri
United States East Tennessee Children's Hospital Knoxville Tennessee
United States Gundersen Lutheran Medical Center La Crosse Wisconsin
United States Rebecca and John Moores UCSD Cancer Center La Jolla California
United States San Antonio Military Pediatric Cancer and Blood Disorders Center Lackland Air Force Base Texas
United States Sunrise Hospital and Medical Center Las Vegas Nevada
United States Norris Cotton Cancer Center Lebanon New Hampshire
United States Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky
United States University of Arkansas for Medical Sciences Little Rock Arkansas
United States Loma Linda University Medical Center Loma Linda California
United States Jonathan Jaques Children's Cancer Center Long Beach California
United States Cedars-Sinai Medical Center Los Angeles California
United States Children's Hospital Los Angeles Los Angeles California
United States Jonsson Comprehensive Cancer Center, UCLA Los Angeles California
United States Kosair Children's Hospital Louisville Kentucky
United States Covenant Children's Hospital Lubbock Texas
United States Medical Center of Central Georgia Macon Georgia
United States Children's Hospital Central California Madera California
United States University of Wisconsin Hospital and Clinics Madison Wisconsin
United States North Shore University Hospital Manhasset New York
United States Marshfield Clinic Marshfield Wisconsin
United States Saint Jude Children's Research Hospital Memphis Tennessee
United States Baptist Hospital of Miami Miami Florida
United States Miami Children's Hospital Miami Florida
United States University of Miami-Jackson Memorial Hospital Miami Florida
United States Midwest Children's Cancer Center Milwaukee Wisconsin
United States Children's Hospitals and Clinics - Minneapolis Minneapolis Minnesota
United States University of South Alabama Medical Center Mobile Alabama
United States West Virginia University Hospitals Morgantown West Virginia
United States Vanderbilt-Ingram Cancer Center Nashville Tennessee
United States Cancer Institute of New Jersey New Brunswick New Jersey
United States Yale Comprehensive Cancer Center New Haven Connecticut
United States Schneider Children's Hospital New Hyde Park New York
United States Children's Hospital of New Orleans New Orleans Louisiana
United States Ochsner Clinic New Orleans Louisiana
United States Tulane University School of Medicine New Orleans Louisiana
United States Columbia Presbyterian Hospital New York New York
United States Memorial Sloan-Kettering Cancer Center New York New York
United States Mount Sinai School of Medicine New York New York
United States New York Presbyterian Hospital - Cornell Campus New York New York
United States Newark Beth Israel Medical Center Newark New Jersey
United States Children's Hospital of the King's Daughters Norfolk Virginia
United States Hope Children's Hospital Oak Lawn Illinois
United States Children's Hospital of Oakland Oakland California
United States Children's Hospital of Oklahoma Oklahoma City Oklahoma
United States Children's Hospital of Omaha Omaha Nebraska
United States University of Nebraska Medical Center Omaha Nebraska
United States Chao Family Comprehensive Cancer Center Orange California
United States Children's Hospital of Orange County Orange California
United States Florida Hospital Cancer Institute Orlando Florida
United States Nemours Children's Clinic-Orlando Orlando Florida
United States Lucile Packard Children's Hospital at Stanford Palo Alto California
United States Lutheran General Hospital Park Ridge Illinois
United States St. Joseph's Hospital and Medical Center Paterson New Jersey
United States Sacred Heart Children's Hospital Pensacola Florida
United States Saint Jude Midwest Affiliate Peoria Illinois
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States St. Christopher's Hospital for Children Philadelphia Pennsylvania
United States Phoenix Children's Hospital Phoenix Arizona
United States Children's Hospital of Pittsburgh Pittsburgh Pennsylvania
United States Doernbecher Children's Hospital Portland Oregon
United States Legacy Emanuel Hospital and Health Center Portland Oregon
United States Naval Medical Center, Portsmouth Portsmouth Virginia
United States Rhode Island Hospital Providence Rhode Island
United States Massey Cancer Center Richmond Virginia
United States Carilion Medical Center for Children Roanoke Virginia
United States James P. Wilmot Cancer Center Rochester New York
United States Mayo Clinic Cancer Center Rochester Minnesota
United States CCOP - Beaumont Royal Oak Michigan
United States William Beaumont Hospital Royal Oak Michigan
United States Sutter Cancer Center Sacramento California
United States University of California Davis Medical Center Sacramento California
United States Cardinal Glennon Children's Hospital Saint Louis Missouri
United States St. Louis Children's Hospital Saint Louis Missouri
United States Children's Hospitals and Clinics of Minnesota Saint Paul Minnesota
United States Huntsman Cancer Institute Salt Lake City Utah
United States Methodist Health Care System San Antonio Texas
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States Children's Hospital San Diego San Diego California
United States Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego San Diego California
United States Kaiser Permanente Medical Center - San Francisco Geary Campus San Francisco California
United States UCSF Comprehensive Cancer Center San Francisco California
United States Santa Barbara Cottage Hospital Santa Barbara California
United States Kaiser Permanente Medical Center - Santa Clara Santa Clara California
United States Memorial Health University Medical Center, Inc. Savannah Georgia
United States Maine Children's Cancer Program Scarborough Maine
United States Children's Hospital and Regional Medical Center - Seattle Seattle Washington
United States Fred Hutchinson Cancer Research Center Seattle Washington
United States Group Health Cooperative Seattle Washington
United States Avera Cancer Institute Sioux Falls South Dakota
United States Sioux Valley Hospital Sioux Falls South Dakota
United States Deaconess Medical Center Spokane Washington
United States Baystate Medical Center Springfield Massachusetts
United States Southern Illinois University School of Medicine Springfield Illinois
United States All Children's Hospital St. Petersburg Florida
United States State University of New York Health Sciences Center - Stony Brook Stony Brook New York
United States Atlantic Health System Summit New Jersey
United States State University of New York - Upstate Medical University Syracuse New York
United States Madigan Army Medical Center Tacoma Washington
United States Mary Bridge Children's Health Center Tacoma Washington
United States Tampa Children's Hospital Tampa Florida
United States Scott and White Memorial Hospital Temple Texas
United States St. Vincent Mercy Medical Center Toledo Ohio
United States Toledo Children's Hospital Toledo Ohio
United States David Grant Medical Center Travis Air Force Base California
United States Arizona Cancer Center Tucson Arizona
United States CCOP - Oklahoma Tulsa Oklahoma
United States Natalie Warren Bryant Cancer Center Tulsa Oklahoma
United States New York Medical College Valhalla New York
United States Children's National Medical Center Washington District of Columbia
United States Lombardi Cancer Center Washington District of Columbia
United States Walter Reed Army Medical Center Washington District of Columbia
United States St. Mary's Hospital West Palm Beach Florida
United States Wesley Medical Center Wichita Kansas
United States Alfred I. Dupont Institute Wilmington Delaware
United States Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina
United States University of Massachusetts Memorial Medical Center - University Campus Worcester Massachusetts
United States Forum Health-Tod Childrens Hospital Youngstown Ohio

Sponsors (2)

Lead Sponsor Collaborator
Children's Oncology Group National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Australia,  Canada,  Netherlands,  New Zealand,  Puerto Rico,  Switzerland, 

References & Publications (1)

Chaleff S, Hurwitz CA, Chang M, Dahl G, Alonzo TA, Weinstein H. Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study. Br J Haematol. 2012 Mar;156(5):649-55. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Event Free Survival EFS will be estimated by Kaplan-Meier31 method. Prognostic factor analyses will be performed descriptively due to the limited sample size. No
See also
  Status Clinical Trial Phase
Recruiting NCT05691608 - MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 N/A
Recruiting NCT04092803 - Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu N/A
Active, not recruiting NCT02530463 - Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome Phase 2
Completed NCT00948064 - Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Phase 2
Completed NCT04474678 - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") N/A
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Recruiting NCT03948529 - RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation Phase 2
Completed NCT01682226 - Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies Phase 2
Completed NCT00003270 - Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer Phase 2
Active, not recruiting NCT02723994 - A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia Phase 2
Terminated NCT02469415 - Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) Phase 2
Recruiting NCT04856215 - 90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia Phase 2
Recruiting NCT06155188 - Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia N/A
Completed NCT00001637 - Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults Phase 2
Active, not recruiting NCT04188678 - Resiliency in Older Adults Undergoing Bone Marrow Transplant N/A
Completed NCT02910583 - Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) Phase 2
Completed NCT01212926 - Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain N/A
Terminated NCT00014560 - Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Phase 1
Recruiting NCT04977024 - SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer Phase 2
Recruiting NCT05866887 - Insomnia Prevention in Children With Acute Lymphoblastic Leukemia N/A